Skip to content
Open access

N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population

Aug 2026 · Journal of Virology · Vol 100 · 0 citations · 55 references
Medicine

TL;DR

It is suggested that the temporary introduction of sites with low glycosylation allows influenza viruses to reduce the immune pressure on antigenic and receptor binding sites of hemagglutinin without significantly compromising viral virulence.

Abstract

ABSTRACT Glycosylation of the influenza A virus hemagglutinin is crucial for viral fitness and immune evasion. The hemagglutinin of contemporary human A(H3N2) influenza A viruses is extensively glycosylated with up to 13 putative glycosylation sites. Glycan types and occupancy of these sites are not uniform: while most are nearly completely occupied by glycans, some, such as those at amino acid residues 45 and 144, are only partially occupied and are evolutionarily unstable. While the effects of highly occupied glycosylated sites of hemagglutinin on A(H3N2) influenza A virus biology are well studied, there is limited information on the functional impact of the low-occupancy glycosylation sites on the viral hemagglutinin. Here, by using reverse-genetics A(H3N2) influenza A viruses lacking glycans at either residue 45 or 144, or both in hemagglutinin, we demonstrate that, despite reduced receptor binding, thermal stability, and fusion, the presence of a low level of glycosylation at these positions does not impact virus growth in Madin-Darby canine kidney epithelial cell culture. In contrast, these low-occupancy sites do affect immune responses in mice, by reducing titers of antibodies that correlate with virus neutralization and protection against influenza disease. We suggest that the temporary introduction of sites with low glycosylation allows influenza viruses to reduce the immune pressure on antigenic and receptor binding sites of hemagglutinin without significantly compromising viral virulence. This mechanism may help support the sustained circulation of A(H3N2) influenza A virus in human populations. IMPORTANCE Many of the glycosylation sites on the hemagglutinin of influenza A viruses are near antigenic sites, such that the glycans block antibody recognition and help evade population immunity. However, glycans may also reduce viral replication and virulence. Glycosylation sites at amino acid residues 45 and 144 of the hemagglutinin of contemporary A(H3N2) influenza A viruses are minimally occupied, with fewer than 10% of the sites containing glycans. This is still sufficient to partially evade antibody-based population immunity, while minimizing the impact on replication and virulence. Over time, A(H3N2) viruses have used both these sites only during limited periods, suggesting that even a low level of glycan occupancy may confer some negative selection pressure that is compensated by evasion of human population immunity. Data from this study provide a better understanding of the mechanisms that allow viruses to evade antibody-based immunity and maintain circulation in the human population. Many of the glycosylation sites on the hemagglutinin of influenza A viruses are near antigenic sites, such that the glycans block antibody recognition and help evade population immunity. However, glycans may also reduce viral replication and virulence. Glycosylation sites at amino acid residues 45 and 144 of the hemagglutinin of contemporary A(H3N2) influenza A viruses are minimally occupied, with fewer than 10% of the sites containing glycans. This is still sufficient to partially evade antibody-based population immunity, while minimizing the impact on replication and virulence. Over time, A(H3N2) viruses have used both these sites only during limited periods, suggesting that even a low level of glycan occupancy may confer some negative selection pressure that is compensated by evasion of human population immunity. Data from this study provide a better understanding of the mechanisms that allow viruses to evade antibody-based immunity and maintain circulation in the human population.

Read PDF

Similar papers

Open access Sep 2026

HIV-1 lentivirus with VSV-G envelope: Complex N glycosylation governs shifts in aggregation and infectivity state at close to physiological pH, serum, and Ca2+ levels

The goal of the study is to determine if the N-glycosylation on a virus affects its diffusion or solution state in different environmental conditions, and if the nature of the solution states has any consequence for the virus infectivity. HIV-1 lentivirus is frequently pseudo-typed with the envelope protein of Vesicula...

T. Chang, Ayobami I. Ogundiran, Andrey Ivanov et al. · 0 citations
Sep 2026

Influenza A virus neuraminidase-GRP78 binding site prediction.

Previous research has shown that there is an interaction between Influenza A viral surface neuraminidase (NA) and the host endoplasmic reticulum chaperone GRP78 in the early phases of NA production in the endoplasmic reticulum. In this study, we predict the binding sites of neuraminidase for H1N1, H3N2, and H5N1 strain...

Yasser M. Gebril, Menna Allah A. Ibrahim, Wael M. Elshemey et al. · 0 citations
Open access Aug 2026

N-linked glycosylation of GETV envelope proteins affect viral infection and pathogenicity

ABSTRACT Getah virus (GETV) is an emerging mosquito-borne pathogen with a broad host range, posing a significant threat to livestock and public health. Although putative N-linked glycosylation sites on its envelope proteins have been reported, their precise functional roles remain uncharacterized. In this study, tunica...

Hui Meng, Tian-Yi Wang, Chun-Xiao Mou et al. · 0 citations
Open access Sep 2026

Dengue virus 2 lacking N153 glycosylation displayed enhanced recognition by neutralizing antibodies

Deglycosylated (N153Q) dengue virus (DENV) mutant shows attenuated infection in a mouse model, mainly due to its increased antibody susceptibility. This is consistent with the neutralization assay showing human monoclonal antibodies 2D22 and C10 are more potent towards the mutant than the wild-type (WT) virus. Here,...

G. Fibriansah, T. Ng, X. Lim et al. · 0 citations
Sep 2026

Unveiling the structural details of the nucleotide-binding protein of an antimicrobial peptide transporter from non-typeable Haemophilus influenzae.

Non-typeable Haemophilus influenzae (NTHi) is an opportunistic extracellular pathogen associated with various respiratory diseases. To combat host antimicrobial peptides, NTHi has developed a specialized transporter named Sap (sensitivity to antimicrobial peptide). Within this transporter, the HiSapF component function...

Kalyan Ghosh, S. P. Kanaujia · 0 citations
Open access Sep 2026

Diminished sialoside binding in novel H5N1 influenza hemagglutinin variants identified in a human patient

In 2024, an adolescent female in British Columbia was hospitalised presenting with severe symptoms including respiratory failure due to infection with a novel H5N1 influenza strain (BC24). Using cryogenic electron microscopy, we show here that the N169 α2,3-linked auto-glycan that is found in the sialic acid binding si...

John H. Ni, Saeid Malek Zadeh, A. Berezuk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.